| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.23▲ | 3.03▲ | 3.03▲ | 3.01▲ | 3.29▲ |
| MA10 | 3.06▲ | 2.98▲ | 2.98▲ | 3.10▲ | 4.66▼ |
| MA20 | 3.05▲ | 3.05▲ | 3.05▲ | 3.21▲ | 6.27▼ |
| MA50 | 3.14▲ | 3.19▲ | 3.21▲ | 4.79▼ | 21.32▼ |
| MA100 | 3.33▼ | 3.83▼ | 4.12▼ | 6.38▼ | 28.87▼ |
| MA200 | 4.53▼ | 5.49▼ | 5.83▼ | 15.65▼ | 35.82▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.051▲ | 0.041▲ | 0.046▲ | 0.102▲ | 0.588▲ |
| RSI | 56.834▲ | 55.306▲ | 54.733▲ | 42.465▼ | 26.182▼ |
| STOCH | 95.433▲ | 56.718 | 55.322 | 16.903▼ | 4.110▼ |
| WILL %R | -13.768▲ | -13.768▲ | -14.388▲ | -23.596▲ | -87.918▼ |
| CCI | 99.005 | 114.699▲ | 100.563▲ | 17.642 | -92.093 |
|
Thursday, November 05, 2026 05:30 AM
Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage immunotherapy company targeting cancer and autoimmune diseases, today announced that data from two clinical ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/11/26 | 2.69 | 3.49 | 2.69 | 3.34 | 97,169 |
| 05/11/26 | 2.95 | 2.995 | 2.66 | 2.69 | 16,710 |
| 04/11/26 | 3.01 | 3.035 | 2.93 | 2.95 | 5,450 |
| 03/11/26 | 3.03 | 3.12 | 2.985 | 2.995 | 12,173 |
| 02/11/26 | 3.10 | 3.1113 | 3.00 | 3.07 | 11,625 |
| 30/10/26 | 3.30 | 3.30 | 3.05 | 3.06 | 10,591 |
| 29/10/26 | 3.04 | 3.55 | 3.04 | 3.33 | 14,038 |
| 28/10/26 | 3.19 | 3.46 | 3.19 | 3.32 | 29,526 |
| 27/10/26 | 3.10 | 3.30 | 3.10 | 3.15 | 13,557 |
| 26/10/26 | 3.28 | 3.28 | 3.05 | 3.10 | 26,998 |
|
|
||||
|
|
||||
|
|